Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis

Objective The benefit of direct-acting antivirals (DAAs) against HCV following successful treatment of hepatocellular carcinoma (HCC) remains controversial. This meta-analysis of individual patient data assessed HCC recurrence risk following DAA administration. Design We pooled the data of 977 conse...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Víctor Sapena, Marco Enea, Ferràn Torres, Ciro Celsa, José Ríos, Giacomo Emanuele Maria Rizzo, Pierre Nahon, Zoe Mariñó, Ryosuke Tateishi, Tatsuya Minami, Angelo Sangiovanni, Xavier Forns, Hidenori Toyoda, S. Brillanti, Fabio Conti, Elisabetta Degasperi, Ming‐Lung Yu, Pei‐Chien Tsai, Kévin Jean, Mohamed El‐Kassas, Hend Ibrahim Shousha, Ashraf Omar, Claudio Zavaglia, Hiroko Nagata, Mina Nakagawa, Yasuhiro Asahina, Amit G. Singal, Caitlin C. Murphy, Mohamed Kohla, Chiara Masetti, Jean‐François Dufour, Nicolás Merchante, Luisa Cavalletto, Liliana Chemello, Stanislas Pol, Javier Crespo, José Luís Calleja, Rosanna Villani, Gaetano Serviddio, Alberto Zanetto, Sarah Shalaby, Francesco Paolo Russo, Rob Bielen, Franco Trevisani, Calogero Cammà, Jordi Bruix, Giuseppe Cabibbo, María Reig
Médium: Revisão
Jazyk:angličtina
Vydáno: 2021
On-line přístup:https://doi.org/10.1136/gutjnl-2020-323663
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!